- News & Events
Webinar - Application of HepatoPac™ Toward Developing an Integrated Understanding of the Disposition and Metabolism of Faldaprevir.
Presented by Diane Ramsden, Boehringer-Ingelheim Pharmaceuticals, Inc. Read More
Publication - Generating an IVIVC for metabolism and liver enrichment of an HCV drug, faldaprevir, using a rat hepatocyte model (HepatoPac™) Read More
Webinar - Utility of Micropatterned Co-Cultures for Drug Toxicity Studies. Presented by Dr. Salman Khetani Read More
Press Release - Hepregen Launches First Human HepatoPac™ Assay Kit To Evaluate Hepatotoxocity in the Laboratory Read more
Press Release - Elizabeth E. Tallett Joins the Hepregen Board of Directors Read more
Press Release - Hepregen Announces Publication of Several Scientific Papers Providing Evidence of the Unprecedented Utility of its HepatoPac™ Products Read more